Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DENOSUMAB for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 7 adverse event reports in the FDA FAERS database where DENOSUMAB was used for Psoriasis.

Most Reported Side Effects for DENOSUMAB

Side Effect Reports % Deaths Hosp.
Off label use 34,612 23.2% 299 730
Death 16,545 11.1% 16,459 663
Osteonecrosis of jaw 8,438 5.7% 303 1,486
Arthralgia 5,890 4.0% 51 557
Pain in extremity 4,541 3.1% 52 530
Back pain 4,465 3.0% 95 515
Pain 4,102 2.8% 97 566
Product storage error 3,621 2.4% 1 31
Fall 3,322 2.2% 159 1,156
Fatigue 3,009 2.0% 189 661
Myalgia 2,965 2.0% 28 268
Bone pain 2,805 1.9% 38 255
Spinal fracture 2,566 1.7% 58 323
Tooth disorder 2,553 1.7% 13 128
Hypocalcaemia 2,345 1.6% 237 1,313

Other Indications for DENOSUMAB

Product used for unknown indication (58,522) Osteoporosis (31,013) Osteoporosis postmenopausal (18,350) Bone disorder (13,297) Metastases to bone (5,083) Prophylaxis (4,541) Osteopenia (2,402) Prostate cancer (1,627) Osteoporotic fracture (1,583) Breast cancer (1,576)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

DENOSUMAB Full Profile All Psoriasis Drugs DENOSUMAB Demographics DENOSUMAB Timeline